View Clinical Trial (Medical Research Study)


Early Menopause Hormone Treatment and Cognition - NCT01046643-48109(Clinical Trial 464722)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Ann Arbor
State:  
MI
Zip Code: 48109
Conditions: Postmenopausal
Purpose: The objective of this study is to evaluate the neurobiological effects of hormone therapy (HT) in healthy early postmenopausal women. The studies proposed in this project seek to define the association between different hormone forms (estradiol only and progesterone only) versus placebo on brain functional measures. The functional measures will include the performance of the volunteers on a comprehensive neuropsychological testing battery, and the brain functional responses to episodic memory (verbal and non-verbal) challenges as well as emotional processing determined with fMRI.
Study summary: Specific Aims Aim 1. To examine the effects of estradiol alone on brain functioning in early post-menopausal women during verbal and non-verbal cognitive tasks. Hypothesis: It is expected that with estradiol treatment brain activation will be more prominent in the hippocampus and prefrontal cortical areas compared to placebo. The magnitude of activation in these regions will be positively correlated with task performance in the scanner and with the results of neuropsychological tests assessing verbal and non-verbal delayed recall. Aim 2. To determine the effects of progesterone alone on brain functioning in early postmenopausal women during verbal and non-verbal cognitive tasks. Hypothesis: It is expected that with progesterone treatment brain activation in the hippocampus and prefrontal cortical areas will be decreased compared to both the placebo condition (within subjects) and the estradiol condition (between subjects). Interindividual variations in the magnitude of activation in these regions will be positively correlated with task performance in the scanner and with the results of neuropsychological tests assessing verbal and non-verbal delayed recall. Aim 3. To determine the individual effects of estradiol and progesterone on brain functioning in early postmenopausal women during emotional processing stimuli. Hypothesis: During negative stimuli estradiol-treated women compared to placebo group, are expected to have increased activity in the amygdala, posterior cingulate, and orbitofrontal cortex, while in progesterone-treated women compared to placebo, decreased activity is expected in these brain regions.
Criteria: Inclusion Criteria: - Postmenopausal women - Ages 45-55, 6 - 36 months from their last menstrual period. Exclusion Criteria: - Left handedness - Acute medical illness - Neurologic illness - Psychiatric illness - Heart disease - Thromboembolic disease - Liver disease - Uncorrected thyroid disease - Diabetes - Neurological disease - Porphyria - Allergy to estradiol - Progesterone or lactose - Lactose intolerance - Claustrophobia - Contraindications to MRI (including pacemakers, surgical clips or metallic surgical devices) - Smoking within the last 3 years - Use of hormones within the last 3 months - Current or past history of substance abuse - History of head injury or loss of consciousness - Medications with actions on the central nervous system - Endometrial lining greater than 5mm - Ovarian pathology on ultrasound - Abnormal mammogram - Migraines - Fasting cholesterol >300 mg/dl, and fasting triglycerides >300 mg/dl. - Subjects with HAM-D score > 8, HAM-A > 6 during screening will not be eligible.
Study is available at: University of Michigan Medical Center
Ann Arbor, MI 48109
United States

Primary Contact:
Anne Tkaczyk, M.S.
Email: tkaczyk@umich.edu
Phone: 734-647-7266

Secondary Contact:
Anne Tkaczyk, M.S.
Email: tkaczyk@umich.edu
Phone: 734-647-7266
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.